June 13, 2016
San Diego, Calif. (Embargoed until 10 a.m. PT, June 13, 2016)—Satoshi Minoshima, MD, PhD, professor of radiology and chairman of the Department of Radiology and Imaging Sciences at the University of Utah, Salt Lake City, Utah, has assumed office as 2016-17 vice president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2016 Annual Meeting, June 11-15, in San Diego, Calif.
Minoshima stated, “As SNMMI vice president-elect, I will promote value-driven practice and strong research and development in nuclear medicine and molecular imaging, with a focus on inter-disciplinary national and international collaborations.” He added, “Our core value as healthcare providers is to help people through compassion, innovation, perseverance, and unequivocal excellence.”
His goals for the year ahead include providing support for the development of new radiotracer-based diagnosis and therapy technologies, as well as extensive outreach to all stakeholders, from patients and referring physicians to payors and policymakers. Minoshima will also help define educational pathways that will ensure the field of molecular imaging remains innovative and a key component of current and future healthcare.
Minoshima earned his MD and PhD from Chiba University School of Medicine in Japan. Prior to his position at the University of Utah, Minoshima served on the faculty of the University of Michigan, as well as the University of Washington, where he was also vice chair for research in the Department of Radiology.
He has published seminal research studies concerning neurodegenerative diseases and other brain disorders using innovative imaging technology. His contributions to the field include discovery of the posterior cingulate abnormality in Alzheimer's disease and invention and worldwide dissemination of diagnostic statistical mapping technology for molecular brain imaging. Minoshima served as president of the SNMMI Brain Imaging Council and currently serves as chair of the SNMMI Scientific Program Committee.
Minoshima’s recognitions include the Tetalman Memorial Award (1996) and Kuhl-Lassen Award (2006) from SNMMI and the Distinguished Scientist Award from the Western Regional SNM (2011). In collaboration with national and international members, Minoshima has created numerous initiatives for the SNMMI annual and mid-winter meetings and has worked on a variety of projects for the society. He has also contributed to a wide range of educational activities that advocate functional brain imaging and promote nuclear medicine and molecular imaging practice.
Other SNMMI officers elected for 2016-17 are Sally W. Schwarz, MS, RPh, BCNP, St. Louis, Mo., as president, and Bennett S. Greenspan, MD, MS, FACNM, FACR, Augusta, Ga., as president-elect. SNMMI Technologist Section officers for 2016-17 are Sara G. Johnson, MBA, CNMT, NCT, FSNMMI-TS, San Diego, Calif., as president, and Kathleen Krisak, CNMT, FSNMMI-TS, Granby, Mass., as president-elect.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI’s more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.